PULMONX CORPORATION Proceeds from Repayment of Loans to Purchase Common Stock
PULMONX CORPORATION (LUNG) reported Proceeds from Repayment of Loans to Purchase Common Stock of $201.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentOfLoansToPurchaseCommonStock · last filed 2026-08-04
- PULMONX CORPORATION proceeds from repayment of loans to purchase common stock for the quarter ending 2026-06-30 was $0.00.
- PULMONX CORPORATION proceeds from repayment of loans to purchase common stock for the quarter ending 2026-03-31 was $201.00K, a 63.72% decline year-over-year.
- PULMONX CORPORATION proceeds from repayment of loans to purchase common stock for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- PULMONX CORPORATION proceeds from repayment of loans to purchase common stock for the quarter ending 2025-09-30 was $200.00K, a 53.60% decline year-over-year.
- PULMONX CORPORATION proceeds from repayment of loans to purchase common stock for fiscal 2025 was $754.00K, a 39.19% decline from fiscal 2024.
- PULMONX CORPORATION proceeds from repayment of loans to purchase common stock for fiscal 2024 was $1.24M, a 4.73% increase from fiscal 2023.
- PULMONX CORPORATION proceeds from repayment of loans to purchase common stock for fiscal 2023 was $1.18M, a 39.03% decline from fiscal 2022.
- PULMONX CORPORATION proceeds from repayment of loans to purchase common stock for fiscal 2022 was $1.94M, a 26.77% decline from fiscal 2021.
| Period end | Proceeds from Repayment of Loans to Purchase Common Stock 3 month | Proceeds from Repayment of Loans to Purchase Common Stock 6 month | Proceeds from Repayment of Loans to Purchase Common Stock 9 month | Proceeds from Repayment of Loans to Purchase Common Stock 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $201.00K 10-Q · filed 2026-08-04 | $201.00K derived: sum of 3 quarters · filed 2026-08-04 | $401.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $201.00K 10-Q · filed 2026-05-04 | $201.00K derived: sum of 2 quarters · filed 2026-05-04 | $401.00K derived: sum of 3 quarters · filed 2026-05-04 | $401.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $200.00K derived: sum of 2 quarters · filed 2026-03-10 | $200.00K derived: sum of 3 quarters · filed 2026-08-04 | $754.00K 10-K · filed 2026-03-10 |
| 2025-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $200.00K derived: sum of 2 quarters · filed 2026-08-04 | $754.00K 10-Q · filed 2025-11-12 | $755.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $554.00K 10-Q · filed 2026-08-04 | $555.00K derived: sum of 3 quarters · filed 2026-08-04 | $986.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $554.00K 10-Q · filed 2026-05-04 | $555.00K derived: sum of 2 quarters · filed 2026-05-04 | $986.00K derived: sum of 3 quarters · filed 2026-05-04 | $986.00K derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $432.00K derived: sum of 2 quarters · filed 2026-03-10 | $432.00K derived: sum of 3 quarters · filed 2026-03-10 | $1.24M 10-K · filed 2026-03-10 |
| 2024-09-30 | $431.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $431.00K derived: sum of 2 quarters · filed 2025-11-12 | $1.24M 10-Q · filed 2025-11-12 | $1.24M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $808.00K 10-Q · filed 2025-08-01 | $808.00K derived: sum of 3 quarters · filed 2025-08-01 | $1.32M derived: sum of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | $808.00K 10-Q · filed 2025-05-02 | $808.00K derived: sum of 2 quarters · filed 2025-05-02 | $1.32M derived: sum of 3 quarters · filed 2025-05-02 | $1.32M derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $508.00K derived: sum of 2 quarters · filed 2025-02-25 | $508.00K derived: sum of 3 quarters · filed 2025-02-25 | $1.18M 10-K · filed 2025-02-25 |
| 2023-09-30 | $508.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $508.00K derived: sum of 2 quarters · filed 2024-11-01 | $1.18M 10-Q · filed 2024-11-01 | $1.18M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $676.00K 10-Q · filed 2024-08-02 | $676.00K derived: sum of 3 quarters · filed 2024-08-02 | $1.51M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $676.00K 10-Q · filed 2024-05-03 | $676.00K derived: sum of 2 quarters · filed 2024-05-03 | $1.51M derived: sum of 3 quarters · filed 2024-05-03 | $1.51M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $834.00K derived: sum of 2 quarters · filed 2024-02-27 | $834.00K derived: sum of 3 quarters · filed 2024-02-27 | $1.94M 10-K · filed 2024-02-27 |
| 2022-09-30 | $834.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $834.00K derived: sum of 2 quarters · filed 2023-11-03 | $1.94M 10-Q · filed 2023-11-03 | $1.94M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $1.11M 10-Q · filed 2023-08-04 | $1.11M derived: sum of 3 quarters · filed 2023-08-04 | $1.77M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $1.11M 10-Q · filed 2023-05-08 | $1.11M derived: sum of 2 quarters · filed 2023-05-08 | $1.77M derived: sum of 3 quarters · filed 2023-05-08 | $3.76M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $660.00K derived: sum of 2 quarters · filed 2023-03-01 | $2.65M derived: sum of 3 quarters · filed 2023-03-01 | $2.65M 10-K · filed 2023-03-01 |
| 2021-09-30 | $660.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.65M derived: sum of 2 quarters · filed 2022-11-08 | $2.65M 10-Q · filed 2022-11-08 | $2.65M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.99M 10-Q · filed 2022-08-08 | $1.99M derived: sum of 3 quarters · filed 2022-08-08 | $1.99M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 | $0.00 derived: sum of 2 quarters · filed 2022-05-09 | $0.00 derived: sum of 3 quarters · filed 2022-05-09 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 10-K · filed 2022-03-01 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |